SCHEMBL1991394

SCHEMBL1991394

COC(=O)[C@H](C)Oc1ccc(F)cc1-c1ccc(S(=O)(=O)c2cccc(F)c2)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
GRM5 P41594 1/20 0.37
NR3C1 P04150 3/20 0.36
PGR P06401 3/20 0.36
ABL1 P00519 1/20 0.35
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
F9 P00740 1/20 0.35
PLAU P00749 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1993975 0.90 ABCB11 (0.48) ABCB11PTGDR2GRM5NR1H4KMT2A
SCHEMBL1992331 0.88 ABCB11 (0.39) ABCB11PTGDR2NR3C1PGRABL1
SCHEMBL1992062 0.84 ABCB11 (0.49) ABCB11PTGDR2ABCC9ABCC8KCNJ11
SCHEMBL1989827 0.83 PTGDR2 (0.44) ABCB11PTGDR2NR3C1PGRABCC9
SCHEMBL1989562 0.83 PTGS2 (0.45) GRM5NR3C1PGRMEN1KMT2A
SCHEMBL2351025 0.82 PTGDR2 (0.40) ABCB11PTGDR2GRM5PLAUNR1H4
SCHEMBL2356017 0.79 CNR1 (0.40) ABCB11PTGDR2PTGS2MMP1MMP2
SCHEMBL14432862 0.79 CNR1 (0.40) ABCB11PTGDR2PTGS2MMP1MMP2
SCHEMBL2351027 0.79 GRM5 (0.39) PTGDR2GRM5ABCC9ABCC8KCNJ11
SCHEMBL1995866 0.78 ABCB11 (0.46) ABCB11PTGDR2MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD ABCB11 193/4885PTGDR2 568/4885GRM5 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.